SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-156226
Filing Date
2016-11-10
Accepted
2016-11-10 16:04:50
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17190_110q.htm 10-Q 967733
2 EX-31.1 a16-17190_1ex31d1.htm EX-31.1 12125
3 EX-31.2 a16-17190_1ex31d2.htm EX-31.2 12130
4 EX-32.1 a16-17190_1ex32d1.htm EX-32.1 6740
  Complete submission text file 0001104659-16-156226.txt   4242379

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20160930.xml EX-101.INS 771454
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20160930.xsd EX-101.SCH 37513
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20160930_cal.xml EX-101.CAL 45747
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20160930_lab.xml EX-101.LAB 363069
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20160930_pre.xml EX-101.PRE 275950
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20160930_def.xml EX-101.DEF 145697
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 161988011
SIC: 2834 Pharmaceutical Preparations